Michael P. Bogenschutz, MD

Conditions and Treatments

Conditions

addiction
social anxiety disorder

Learn more about conditions we treat at NYU Langone:

Addiction

Credentials

Positions

Professor, Department of Psychiatry at NYU Grossman School of Medicine
Director, NYU Langone Center for Psychedelic Medicine

Board Certifications

American Board of Psychiatry & Neurology (Addiction Psychiatry), 1997
American Board of Psychiatry & Neurology - Psychiatry, 1995

Education and Training

Residency, The Cambridge Hospital, Psychiatry, 1994
MD from Harvard University, 1990

Is this your profile?

Edit profile

Insurance Plans Accepted

This provider accepts the following insurance plans.

Medicare

Railroad Medicare

UnitedHealthcare Top Tier

This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Michael P. Bogenschutz, MD does not accept insurance.

Locations and Appointments

NYU Psychiatry Associates

1 Park Avenue, 8th Floor, New York, NY 10016

View Map

Phone

212-263-7419

Fax

212-263-7460

Research Academic Contact

Academic office

1 Park Avenue

8th Floor

New York, NY 10016

Phone

212-263-7419

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *

represents one publication

Loading...

*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Clinical Trials and Research Studies

Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

Learn More

View All Research Studies (1)

Publications

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review

Kiluk, Brian D; Kleykamp, Bethea A; Comer, Sandra D; Griffiths, Roland R; Huhn, Andrew S; Johnson, Matthew W; Kampman, Kyle M; Pravetoni, Marco; Preston, Kenzie L; Vandrey, Ryan; Bergeria, Cecilia L; Bogenschutz, Michael P; Brown, Randall T; Dunn, Kelly E; Dworkin, Robert H; Finan, Patrick H; Hendricks, Peter S; Houtsmuller, Elisabeth J; Kosten, Thomas R; Lee, Dustin C; Levin, Frances R; McRae-Clark, Aimee; Raison, Charles L; Rasmussen, Kurt; Turk, Dennis C; Weiss, Roger D; Strain, Eric C

JAMA psychiatry. 2023 Jan 01; 80(1):84-92
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

O'Donnell, Kelley C; Mennenga, Sarah E; Owens, Lindsey; Podrebarac, Samantha K; Baron, Tara; Rotrosen, John; Ross, Stephen; Forcehimes, Alyssa A; Bogenschutz, Michael P

Contemporary clinical trials. 2022 Nov 01; 106976
Comparison of self-reported alcohol consumption and ethyl glucuronide in hair in a sample of 60+ year -olds treated for DSM-5 alcohol use disorder

Nielsen, Dorthe GrÃ¼ner; Andersen, Kjeld; Nielsen, Anette SÃ¸gaard; Nielsen, Flemming; Behrendt, Silke; Bilberg, Randi; Bogenschutz, Michael; BÃ¼hringer, Gerhard; Mellentin, Angelina Isabella

Addiction biology. 2022 Nov ; 27(6):e13231

Read All Publications (111)

Conditions We Treat

Our Story

Michael P. Bogenschutz, MD

About Me

Conditions and Treatments

Conditions

Learn more about conditions we treat at NYU Langone:

Credentials

Positions

Board Certifications

Education and Training

Insurance Plans Accepted

Locations and Appointments

NYU Psychiatry Associates

Phone

Fax

Research Academic Contact

Academic office

Phone

Research Interests Timeline

Clinical Trials and Research Studies

Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

Publications

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

Comparison of self-reported alcohol consumption and ethyl glucuronide in hair in a sample of 60+ year -olds treated for DSM-5 alcohol use disorder

Related News